Potassium Absorption and Peak Serum Levels After Repletion
Oral potassium chloride is absorbed rapidly—primarily from the stomach—with peak serum potassium levels occurring within 1 hour of administration, which may be faster than IV administration in severe hypokalemia. 1
Absorption Kinetics
Oral/Enteral Route
- Absorption occurs rapidly from the gastrointestinal tract, with evidence showing virtually all dietary potassium is absorbed in the intestine 2
- Peak serum concentration is reached within 1 hour when liquid potassium chloride formulations are used 1, 3
- In severe hypokalemia (K+ 2.3-2.4 mEq/L), enteral administration of 26.8 mEq KCl increased serum potassium by 0.7 mmol/L within 1 hour 1
- The stomach appears to be the primary site of rapid absorption for liquid formulations 3
Intravenous Route
- Peak levels occur at the completion of the infusion (typically 1 hour for standard protocols) 4
- IV infusions of 20-40 mmol over 1 hour produced dose-dependent increases:
- 20 mmol: 0.5 ± 0.3 mmol/L increase
- 30 mmol: 0.9 ± 0.4 mmol/L increase
- 40 mmol: 1.1 ± 0.4 mmol/L increase 4
Comparative Effectiveness
The enteral and IV routes demonstrate equivalent efficacy for potassium repletion. Multiple studies confirm no clinically significant difference in dose-response between routes:
- Enteral vs IV produced similar potassium increases: 0.27 mmol/L vs 0.25 mmol/L per 20 mmol dose (p=0.73) 5
- In pediatric cardiac ICU patients, mean changes were 0.86 mmol/L (enteral) vs 0.82 mmol/L (IV), with no statistical difference (p=0.86) 6
- Success rates for achieving target potassium levels were comparable: 59% (enteral) vs 61% (IV) 5
Clinical Implications
Route Selection
Despite equivalent efficacy and the fact that 77% of ICU patients are eligible for enteral administration 5, IV remains overutilized. The enteral route offers advantages:
- Equally effective dose-response
- Potentially faster peak in severe hypokalemia
- Avoids IV access complications
- Lower cost
Important Caveats
- Rebound hypokalemia can occur after 2 hours with temporizing measures (insulin, beta-agonists, bicarbonate) that shift potassium intracellularly without increasing excretion 7
- Urinary potassium excretion increases during and after repletion, particularly with doses ≥30 mmol 4
- Peak levels are independent of baseline renal function 4
- Serum and plasma potassium differ by 0.2-0.4 mmol/L, with serum typically higher—ensure consistent specimen type when monitoring 8
Monitoring Timing
Based on absorption kinetics, recheck serum potassium 1 hour after oral or IV repletion to assess response and guide further dosing. This timing captures peak levels for both routes and allows for timely additional repletion if needed.